At Sunrise Medical, we specialize in the OEM/ODM development of Semaglutide injection pens tailored for GLP-1 receptor agonist therapies, widely used in weight management and type 2 diabetes care. Our pens are built to deliver accurate, controlled dosing of viscous peptide formulations, while maintaining ease of use and patient safety.
Our solutions include both reusable and disposable injection pen systems, compatible with 1.5ml or 3ml Semaglutide cartridges. Designed for pharmaceutical brands, clinical researchers, and regional distributors, each pen ensures:
Adjustable dosing from 0.01ml to 0.4ml.
Stable performance with high-viscosity formulations.
Customization options for logo, color, packaging, and housing.
ISO 11608 compliance and CE-certification readiness.
OEM support for clinical trials, market launch, and private label supply.
Whether for self-injection, clinic use, or trial deployment, our pens are designed to be fully compatible with standard cartridge sizes and Luer needle systems, offering dependable integration into your treatment workflow.
We also offer regulatory support, sterilizable components, and scalable production for international markets — including Europe, Middle East, North America, and Southeast Asia.
